Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001493152-26-043246

CEO & President bought 24,000 shares at $0.21 ($4,992)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Equels Thomas K CEO & President 2026-09-17 Purchase +24,000 $0.21 $4,992 126,822 D
Open-market purchases · 24,000 sh · avg $0.21 · $4,992
Loading xslF345X06/ownership.xml…